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Abstract
Turner’s syndrome (caused by monosomy of chromosome X) is one of the most common chromosomal abnormalities in
females. Although 3% of all pregnancies start with XO embryos, 99% of these pregnancies terminate spontaneously during
the first trimester. The common genetic explanation for the early lethality of monosomy X embryos, as well as the
phenotype of surviving individuals is haploinsufficiency of pseudoautosomal genes on the X chromosome. Another possible
mechanism is null expression of imprinted genes on the X chromosome due to the loss of the expressed allele. In contrast
to humans, XO mice are viable, and fertile. Thus, neither cells from patients nor mouse models can be used in order to study
the cause of early lethality in XO embryos. Human embryonic stem cells (HESCs) can differentiate in culture into cells from
the three embryonic germ layers as well as into extraembryonic cells. These cells have been shown to have great value in
modeling human developmental genetic disorders. In order to study the reasons for the early lethality of 45,XO embryos we
have isolated HESCs that have spontaneously lost one of their sex chromosomes. To examine the possibility that imprinted
genes on the X chromosome play a role in the phenotype of XO embryos, we have identified genes that were no longer
expressed in the mutant cells. None of these genes showed a monoallelic expression in XX cells, implying that imprinting is
not playing a major role in the phenotype of XO embryos. To suggest an explanation for the embryonic lethality caused by
monosomy X, we have differentiated the XO HESCs in vitro an in vivo. DNA microarray analysis of the differentiated cells
enabled us to compare the expression of tissue specific genes in XO and XX cells. The tissue that showed the most
significant differences between the clones was the placenta. Many placental genes are expressed at much higher levels in
XX cells in compare to XO cells. Thus, we suggest that abnormal placental differentiation as a result of haploinsufficiency of
X-linked pseudoautosomal genes causes the early lethality in XO human embryos.
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Introduction
Turner’s Syndrome results from X chromosome monosomy.
This syndrome described in 1938 [1], is the most common sex
chromosome abnormality in females [2]. Females with Turner’s
syndrome haveseveralcharacteristic phenotypes,the most common
are growth failure, gonadal dysgenesis and webbed neck [2,3]. 3%
of all pregnancies start with XO embryos, however it is estimated
that only 1% of these embryos survive to term [2,4]. Moreover,
among the Turner’s syndrome patients more than 50% are mosaic
(e.g. 45,X0/46,XX) [2] which may suggest that the frequency of
survival of 45,XO fetuses is even less than 1%. Most of the
miscarriages of XO embryos occur during the first trimester [4].
Several molecular mechanisms have been suggested to explain
the phenotypes observed in Turner’s syndrome [5]. Of these
mechanisms the most plausible explanation is haploinsufficiency of
genes that are normally expressed from the two X chromosomes.
In this case, the affected phenotypes are the result of the dosage of
the specific gene. Another logical explanation is the presence of
imprinted genes on the X chromosome, which are expressed in a
mono-allelic fashion. In this case, the loss of the expressed
chromosome will result in null expression of the gene. The
underlying assumption of these two proposed mechanisms is that
the involved genes must escape X inactivation. Otherwise,
according to the imprinting hypothesis there will be no expression
of the genes in half of the cells upon X inactivation, and according
to the haploinsufficiency hypothesis all the cells will not have
sufficient dosage of the gene upon X inactivation. In addition,
according to the haploinsufficiency hypothesis the gene must have
an active homolog on the Y chromosome, so that the expression
levels in males will be equal to those in females. One major
argument against the imprinting hypothesis is that it predicts that
the phenotype will depend upon the parental origin of the single X
chromosome and there is very little evidence for this [5].
Based on the haploinsufficiency assumption, 3 candidate genes
have been proposed in order to explain the etiology of Turner’s
syndrome. Fisher et al. [6] has isolated the RPS4X (NM_001007)
and its homolog RPS4Y (NM_001007) genes. Another gene that
has been suggested to have a role in Turner’s syndrome
phenotypes is the ZFX gene [7]. However others have argued
that haploinsufficiency in these genes are not the cause of Turner’s
syndrome [5,8].
The only gene that has been proven to be associated with one of
the phenotypes of Turner’s syndrome is SHOX (NM_000451).
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positional cloning of an area in pesudoautosomal region 1 (PAR1)
which was deleted in individual with short stature.
One major disadvantage in previous studies of Turner’s
syndrome is that all of the patients represent the exceptional case
(1%) that survived to term. Thus no conclusion about the most
prevalent phenotype of the 45,XO karyotype, namely the early
lethality, can be reached by studying these patients.
It has been shown that XO mice, in contrast to humans, are
viable and are anatomically normal and fertile [11]. Hence XO
mice can not be used as a model for Turner’s syndrome and for the
embryonic lethality caused in monosomy of the X chromosome.
Human embryonic stem cells (HESCs) can differentiate in
culture into structures called embryoid bodies [12]. In these EBs
one can detect cells from the three embryonic germ layers as well
as extra-embryonic cells. Moreover, genes that characterize
gastrulation and organogenesis in mammals are temporally
regulated during differentiation of HESCs into EBs [13,14]. In
addition, HESCs can differentiate into the three embryonic germ
layers in vivo when injected into SCID mice [15]. Thus, these
pluripotent cells have a great value in studying human
developmental genetic diseases, particularly in cases where the
mouse model fails to recapitulate the phenotypes seen in the
patients. Previously, we have utilized HESCs in order to study two
genetic diseases. We created a model of Lesch-Nyhan syndrome
by gene targeting of the HPRT1 gene (NM_000194) [16], and a
model of Fragile X syndrome by deriving a new HESC line from
an affected blastocyst identified by preimplantation genetic
diagnosis (PGD) to carry fragile X syndrome [17].
In our current research we have used HESCs in order to study
the cause of miscarriage in XO embryos. Since most of the XO
embryos die during the first trimester [4], HESCs, that
differentiate into various embryonic cells, can be the best source
of cells for studying the reasons for the early lethality in XO
embryos. We have thus isolated HESCs that have spontaneously
lost an X chromosome. By analyzing the gene expression profile of
the cells upon differentiation we have searched for affected tissues
and for new candidate genes to explain the lethality in 45,XO
human embryos.
We suggest that loss of the X chromosome causes a defect in
differentiation of HESCs into the trophectoderm placenta.
Materials and Methods
Cell Culture
HESC lines H9, HUES9, and I3 were cultured as previously
described [12,18]. Wild-type HESCs were transfected with
pEGFP-N1 plasmid (Clontech) using the calcium phosphate
method as described previously [19]. Stably transfected clones
were established by neomycin selection (0.1 mg/ml, Sigma)
following transfection. Some of the clones have a t(1;17)
translocation which appear also in the WT cells.
Undifferentiated cells were trypsinized and induced to form EBs
by allowing them to aggregate in suspension culture by growing
them in nonadherent plastic petri bacterial dishes in the absence of
bFGF as previously described [12,18]. EBs were collected for
analysis following 30 days of cell aggregation in culture.
Induction of Teratomas
All animal experiments were conducted under the supervision of
the Hebrew University Faculty of Sciences Animal Care and Use
Committee (license NS-01-05). Teratomas were formed by
injection of 1–5610
6 ES cells, under the kidney capsule of
SCID/beige mice. Teratomas were isolated 5–8 weeks following
injection.
RNA extraction and RT-PCR analysis
RNA was extracted using Total RNA Extraction kit (RBC) or
TRI-reagent (Sigma) for total RNA isolation according to the
manufacturer’s instructions. cDNA was synthesized using random
hexamer primers. Amplification was performed using RedTaq
ReadyMix PCR reaction mix (Sigma) or FastStart Taq DNA
polymerase (Roche) for products longer than 1 kb. PCR
conditions for most of the reaction include a first step of 3 minutes
or 6 minutes (for cDNA and gDNA respectively) at 94uC, a second
step of 35 cycles of 30 seconds at 94uC, 30 seconds at 60uC, 1–
3 minute at 72uC (depened on the product’s length) and a final
step of 10 minutes at 72uC.
The conditions for the Amelogenin genes were: 94uC for 5 min
and than 35 cycles of 94uC for 45 sec 55uC for 45 sec and 72uC
for 1 min and then a final step of 10 minutes at 72uC
Primers are listed in supplementary Table S3. Final products
were examined by gel electrophoresis on 1–2% agarose ethidium
bromide-stained gels.
qRTPCR were carried out using either SYBER Green ROX
Mix (ABgene) or TaqMan probes (Applied Biosystems) with
TaqMan universal master mix (Roche), according to the
manufacturer’s instructions using the 7300 Real-Time PCR
System (Applied Biosystems). Some of qRTPCR reactions were
performed using the TaqManH Human Stem Cell Pluripotency
Array (4385344) according to the manufacturer’s instructions. For
description of primers see supplementary Tables S4, S5.
FISH analysis
Cells were fixed with methanol and acetic acid (3:1). Fluorescent
in situ hybridization was carried out according to the manufac-
turer’s recommendations and as described previously [20] using
probe mixtures specific for chromosomes X, Y and 17 [Vysis,
Downers Grove, IL] The criterion for signal scoring was that
signals had to be at a minimum of a signal’s width apart to be
scored as two separate signals. Confocal imaging was performed
using an MRC-1024 Bio-Rad confocal scan head coupled to a
Zeiss Axiovert 135 M inverted microscope (Carl Zeiss, Jena,
Germany).
Microsatellite DNA Analysis
Genomic DNA was extracted from culture cells using EZ-DNA
kit (Biological Industries, Kibbutz Beit Haemek, Israel) according
to the manufacturer’s instructions. Genotyping was performed at
the Center for Genomic Technologies at the Hebrew University of
Jerusalem, Israel, using the dxs1106 and dxs1060 markers from
the Genethon human linkage map (ABI PRISM Linkage Mapping
Set MD10; Applied BioSystems, Foster City, CA). Polymerase
chain reaction (PCR) amplification of individual markers (fluores-
cence-dye-labeled forward primer and unlabeled reverse primer)
was performed in a PTC 225 DNA Engine (Bio-Rad, Hercules,
CA) using 25–30 ng of genomic DNA, 6 pmoles of each primer,
1.5 mM MgCl2, 0.14 mM deoxynucleoside-5-triphosphate, 16
PCR Gold Buffer and 0.4 units of AmpliTaq Gold DNA
Polymerase (both from Applied Biosystems) in a total volume of
10 ml. PCR conditions were as follows: an initial 12 minutes
denaturation at 95uC, 10 cycles of 15 seconds at 94uC, 15 seconds
at 55uC and 30 seconds at 72uC, 10 minutes at 72uC, and hold
forever at 10uC. After amplification, 1–2 ml were sampled into
9 ml of loading buffer (formamide with GeneScan-400HD [ROX]
size standard; Applied Biosystems). PCR product electrophoresis
and detection were performed using the 3700 Automated DNA
Turner Syndrome in HESCs
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performed using GENSCAN and GENOTYPER software
(Applied Biosystems).
DNA Microarray Analysis
Total RNA was extracted according to the manufacturer’s
protocol (Affymetrix, Santa Clara, CA, http://www.affymetrix.
com) from populations of undifferentiated, in vitro and in vivo
differentiated cells derived from normal and XO HESCs.
Hybridization to the U133A microarrays, washing, and scanning
were performed according to the manufacturer’s protocol
(Affymetrix), and expression patterns were compared between
samples. Signals were normalized by dividing each probe in the
average value of the DNA microarray and scaled to a mean value
of 100, to avoid differences between different DNA microarrays
and experiments. Probes were then floored to a value of 20 to
avoid superficially high ratios in respect to non expressed probes.
In each case, two samples of XO clones were compared to three
samples of normal cells. Volcano plots were generated using
Partek software (Partek Inc. St. Louis, MO.; http//:www.partek.
com).
SNP analysis
DNA and cDNA were subjected to PCR and RT-PCR,
respectively, using the primers listed in supplementary Table S6.
The PCR products was purified and subjected to fluorescent
dideoxy sequencing. In order to avoid DNA contamination in the
RT-PCR, the primers for the RT-PCR were chosen from different
exons. In cases that the PCR products were longer than 2 kb
nested RT-PCR was performed
Results
Isolation of 45,XO HESCs clones
Our aim was to isolate 45,XO human embryonic stem cells
(HESCs) and study their differentiation in culture. In order to
estimate the frequency of spontaneous X or Y chromosome loss (in
XX and XY cell lines, respectively) during in vitro culture of
HESCs, we performed FISH analysis with probes against X, Y
and the autosomal 17 chromosome (as a control) see Figure 1A.
The results of the FISH analysis of 200 cells for two HESC lines
are summarized in a table in Figure 1B. Overall we observed
2.4%–5% of loss of sex chromosomes. In H13 HESC line at
passage 22 we could not detect any cells which had lost the Y
chromosome, while in passage 44 of the same line 2.4% of the cells
had lost the Y chromosome resulting in XO cells. This data
suggesting a correlation between the passage number, and the
frequency of the loss of sex chromosomes are in agreement with a
previous study which reports a frequency of 2% in the loss of the Y
chromosome in mouse ESCs [21]. Based on the relatively high
frequency of X and Y chromosome loss as determined by the
FISH analysis we have utilized a simple approach in order to
isolate HESC clones that had lost one of their X chromosomes (in
the case of female line) or their Y chromosome (in the case of male
line). In order to ensure that each clone was originated from a
single cell, the HESCs were transfected with a plasmid carrying
the neo-resistance gene. Every colony that survived G418 selection
was considered to be a ‘‘single cell clone’’ and was plated in a
separate well. DNA was isolated from each clone and analyzed by
PCR to allow the identification of X or Y chromosome loss. In
order to detect 45,XO clones that originate from 46,XX cells we
examined several heterozygous polymorphic microsattalites on the
X chromosome. The loss of the X chromosome results in the
disappearance of one of these polymorphic markers see Figure 1C.
In order to detect 45,XO clones that originate from 46,XY cells
we utilized DNA primers for the Amelogenin gene. These primers
distinguish between Amelogenin X and its Amelogenin Y
homolog. Clones that lost their Y chromosome show only the
Amelogenin X product, see Figure 1D. Karyotype analysis of one
of the XO clones and of its original WT XX HESC line (H9) is
shown in Figure 1E. About 3% (5/166) of the XX and 1.5% (1/
67) of the XY clones were found to become XO clones. These
results are in accordance with our FISH results.
Searching of imprinted genes on the X chromosome
The phenotype of Turner’s syndrome was suggested to result
from haploinsufficiency of pseudoautosomal gene/s on the X
chromosome. It was also suggested that imprinted gene/s on the X
chromosome are also involved in the phenotype (Figure 2A). Thus,
we decided to search for developmentally regulated imprinted
genes on the X chromosome in HESCs and in differentiated cells
derived from HESCs. In order to search for this type of gene we
set two criteria: 1. The gene has to be either pseudoautosomal or
escape X inactivation, 2. The gene has to be expressed in XX cells
but not expressed (or expressed at a very low level) in XO cells. 37
genes that escape X inactivation were analyzed in our microarray
(Affymetyrix). Out of these genes, 21 genes are expressed in
undifferentiated HESCs or in HESCs that underwent differenti-
ation. From these genes we have identified only three X linked
genes – ARSE (NM_000047), STS (NM_000351) and TBL1X
(NM_005647) that fulfill the above criteria (see Figure 2). These
genes escape X inactivation [22,23] and are expressed in XX cells
but not in XO cells. CXorf9 (NM_018990) is an example of a gene
that is expressed in XX cells but not in XO cells, but undergo
normal X inactivation; this gene was not expected to be an
imprinted gene and served as control. XSIT (NR_001564) should
be activated only in cells that have two or more X chromosomes
and therefore it was expected that it will not be expressed at all in
XO cells. In order to examine whether ARSE, STS and TBL1X
are indeed expressed in a monoallelic manner, we looked for
heterozygous SNPs in the DNA and mRNA molecules in these
genes. In imprinted genes, it is expected that only one allele is
expressed at the mRNA level, and thus the heterozygous SNP will
appear as homozygous when sequencing the cDNA. None of the
three candidate genes showed monoallelic expression, see Figure 2.
Thus, according to our criteria, we could not identify imprinted
genes on chromosome X.
Cell specific effects of X chromosome loss
The fact that 99% of XO fetuses are lost during the first
trimester [3] suggests that the early lethality of XO embryos results
from a problem during human organogenesis. Human embryonic
stem cells can differentiate in vitro and in vivo into extra-embryonic
cells as well as into cells of the three embryonic germ layers [12].
Thus, we have decided to compare the differentiation of WT
HESCs to that of XO HESCs. Using the Affymetrix U133A
micryoarray we have studied both in vitro differentiation [9] and in
vivo differentiation (teratomas) of HESCs. Since we wished to
identify the differentiated cell types that are affected in XO cells,
we divided the gene expression microarray data into lists of genes
enriched in different tissues, and compared the gene expression of
WT and XO differentiated HESCs. The assignment of genes into
different tissues was performed according to the Gene Expression
Atlas analysis [24]. Genes were determined to be highly enriched
in a specific tissue if the ratio of their expression in the specific
tissue was 30–50 fold higher than the median of its expression
among all of the tissues in the analysis (note that this criterion
doesn’t confirm tissue specificity but rather, enrichment in a
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PLoS ONE | www.plosone.org 3 January 2009 | Volume 4 | Issue 1 | e4175Figure 1. Isolation of XO clones from XX and XY HESCs. A. The frequency of X or Y chromosome loss in HESCs were estimated by FISH analysis.
Shown are results for X chromosome (Green) Y chromosome (Yellow) and chromosome 17 (Blue), for H9 (XX) cells, BGO1 (XY cells) and a clone of H9
that has lost one of its X chromosomes. B. Summary of the % of XO cells analyzed by FISH. The analyzed samples were either male H13 cells passage
22 and passage 44, or female H9 cells, passage 52. In each experiment 200 cells were analyzed. C. Analysis of two polymorphic markers (DXS1106 and
DXS1060) on the X chromosome that are heterozygous in H9 cells. XO cells retain only one of the markers. D. PCR products of primers that distinguish
between Amelogenin X and Amelogenin Y genes. XY cells (BG01) have two products whereas XX cells (H9) have only one product. XY cells that have
lost the Y chromosome amplify only one band. E. Karyotype analysis of XX and XO cells. Note that in the XO cells only one X chromosome is shown.
doi:10.1371/journal.pone.0004175.g001
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Table S1. Using the above list we have compared the expression
levels in XX and XO HESCs in several different tissues. The only
tissue where many genes were expressed at higher levels in WT
cells as compared to XO cells both upon in vivo and in vitro
differentiation was the placenta see Figure 3A. (see supplementary
Table S2). This is in contrast to other tissue-enriched genes that
were examined, see Figure 3B. Several genes of the fetal brain
were also expressed at higher levels in WT cells, however, in the
fetal brain there were also genes that were expressed at higher level
in the XO cells.
The microarray results were confirmed by qRTPCR as shown
in Figure 4. Except for one gene (FAM46A), all placental genes
were expressed at least 5 fold higher in the WT cells as compared
to the XO cells. On the other hand, we did not observe significant
differences in the expression levels of genes representing the three
embryonic germ layers between WT and XO cells.
Discussion
One of the most important uses of HESCs is modeling for
human developmental genetic diseases [16,17,25]. There are
many developmental diseases that cannot be studied by animal
models since the mutant animal does not recapitulate the human
phenotype. In addition, many of these developmental disorders
cannot be studied by cells from patients since these cells are
Figure 3. Comparison of gene expression in WT and in XO cells upon in vitro and in vivo differentiation. Gene expression levels were
determined by U133A DNA microarray. Every dot represents one probe in the DNA microarray. In each plot the X axis represents fold induction in the
expression levels of WT cells over XO cells (right side of the scale) and of Xo cells over WT cells (left side of the scale). The Y axis represents the P-value
for each gene. For more details on the bioinformatic analysis see Materials and Methods. A. Analysis of genes specific to the placenta. B. Analysis of
genes specific to the heart, fetal lung, fetal liver, fetal brain and whole blood. EBs – in vitro differentiation of HESCs. Teratoma – in vivo differentiation
of HESCs. Solid vertical lines represents.2 fold higher level of expression solid horizontal line represent P-value=0.05.
doi:10.1371/journal.pone.0004175.g003
Figure 2. Searching for monoallelic expression in X chromosome. A. A scheme demonstrating the differences between the
haploinsufficiency hypothesis and the imprinting hypothesis to explain the phenotype in X monosomy. Green dots represent expressed alleles
and red dots represent silenced alleles. Note that according to the imprinted genes hypothesis there is no expression of the remaining allele in XO
cells. B. Expression levels of several genes on the X chromosome whose expression is much higher in WT than in XO HESCs. The expression levels of
STS, XIST and CXorf9 are shown in 30 d EBs and of ARSE and TBL1X in undifferentiated cells. XX – average of three microarray analyses of diploid
HESCs. XO – average of two XO clones that have lost the same X chromosome. C. Searching for monoallelic expression in the candidate genes by SNP
analysis at the DNA and cDNA levels.
doi:10.1371/journal.pone.0004175.g002
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complementary model system that overcomes these impediments.
In order to model genetic diseases by HESCs, one must have
HESCs carrying a specific mutation. Several ways have been
suggested for this purpose [25,26]. Previously we have created a
model for Lesch-Nyhan disease by gene targeting of the HPRT1
gene [16]. Later, we have established a model for Fragile X
syndrome by the derivation of a new HESC line from a blastocyst
identified by preimplantation genetic diagnosis (PGD) as a carrier
of the Fragile X syndrome mutation [17]. In the current work we
have used HESCs that have spontaneously lost one of their sex
chromosomes in order to study the basis for the early lethality in
45,XO embryos. Approximately 3% of the pregnancy start with
45,XO embryos, however up to 99% of these embryos are
spontaneously miscarried [3], most of them during the first
trimester [4]. We have estimated that the frequency of
spontaneous loss of X or Y chromosomes is 2–5%. The most
frequent chromosomal aberration in HESCs are trisomies of 12,
17, X chromosome [27]. Although a few other chromosomal
aberrations were also reported [27], the loss of either X or Y
chromosomes during the culture of HESCs has not been
previously described, probably since it is too rare to be found in
regular karyotypic analysis. However the ratio of Y chromosome
loss that we observed in HESCs is similar to the ratio reported by
Eggan et al. in mouse ESCs [21]. In addition, the frequency of sex
chromosome loss was higher in higher passage than in lower
passage cells as demonstrated for other chromosomal aberrations
in HESCs [28,29].
Recently, in a milestone experiment, Takahashi and Yamanaka
[30] have shown reprogramming of mouse somatic cells into
pluripotent, embryonic-like cells by the ectopic expression of only
a four genes. A few reports that followed the initial experiment
have demonstrated reprogramming of human adult cells into
induced pluripotent stem cells (iPS) [31–33]. Reprogramming of
human somatic cells from affected individuals may enable us to
generate models of human genetic diseases from cells of virtually
any disorder, and thus open a new window of opportunity for
modeling human genetic diseases [31–33]. However, generation of
iPS from Turner’s syndrome patients might not advance our
understanding on the early lethality, since the patients are the
exceptional cases that survived to term. Thus, one may need to
study HESCs (and not iPS cells) with X monosomy to be able to
analyze the developmental phenotype.
Our XO clones were established from the H9 HESC line. It has
been shown in our lab that this line undergoes X inactivation only
upon differentiation [34]. As expected, our XO clones didn’t
express XIST upon differentiation and the remaining X
chromosome was active. Thus, we were able to isolate XO clones
that have lost one of their X chromosomes.
In order to study the effect of the XO karyotype, we compared
the transcriptional profiles of WT and XO clones. Among the
different tissues that we studied, the only tissue that showed a
significance upregulation upon both in vivo and in vitro differenti-
ation was the placenta. Thus, we suggest that at least one of the
reasons for the early lethality of XO embryos is abnormal
placental development. The differences that we observed in the
fetal brain may point to a more complex effect of XO monosomy,
where some genes underwent down regulation upon X chromo-
some loss while others were upregulated. The fact that these results
are reproducible in different XO clones suggests that the reason
for the abnormal placental differentiation is indeed the lost of the
X chromosome and not other genetic instabilities events.
In a detailed study of 160 spontaneous aborted 45,XO embryos
as well as data from the literature Canki et al. [35] divided the
aborted fetuses into 4 groups according to their morphology. Two
out of the four groups which contain 70% of the total number of
samples demonstrate early lethality in XO embryos even before
mature embryonic tissues are visible. Our results which point to
Figure 4. Confirmation of the DNA microarray data by qRT-PCR. Relative expression levels of WT vs. XO cells for several genes enriched in
either the placenta, or in tissues that correspond to the ectoderm, endoderm or mesoderm embryonic germ layers. The genes were analyzed by qRT-
PCR. The solid line represents equal expression in WT and XO cells. * represents p value,0.05 and ** represents p value,0.01.
doi:10.1371/journal.pone.0004175.g004
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observation that many embryos had ruptured sacs. Based on an
extensive study of the gene expression patterns in human placenta
[36], we conclude that the down regulation in the expression of the
placental genes in the XO clones, includes genes of the amnion,
chorion, and villus parenchyma. Thus, we propose that the effect
of the monosomy X on the placental differentiation is very early
and therefore, has a general influence on the various components
of the placenta. Mouse ES cells do not readily differentiate into the
trophectoderm. In contrast, BMP4 was shown to efficiently direct
differentiation of hESCs into the trophoblast [37]. In our system
we have examined the differentiation of hESCs into placental cells
in vitro, in mature embryoid bodies, and in vivo, in teratomas. Since
in these two systems many different cell types exist, the various cell
lineages served as internal controls and allow us to document a
specific effect on the placental genes in the XO cells.
One possible mechanism that has been suggested to explain the
etiology of early lethality in XO embryos is the presence of
imprinted genes on the X chromosmes [5]. Using our XO HESCs
we were not able to identify any imprinted genes on the X
chromosome. We cannot rule out the possibility that there are X-
linked imprinted genes which do not expressed in HESCs or upon
in-vitro and in-vivo differentiation, and thus were not identified by
our method. However, the fact that most of the XO embryos die
during the first trimester, implies that an early and general
developmental process is affected by the lost of the X
chromosome. Spontaneous differentiation of HESCs can mimic
the gastrulation and the formation of the three embryonic germ
layers as well as the extraembryonic cells [13,14]. Therefore, we
assume that our system is sensitive enough to identify imprinted
genes that have such a dramatic effect embryonic development,
and that the fact that we didn’t find imprinted X-linked genes,
suggests that the early lethality in XO embryos is not caused by
null expression of this type of genes.
The most common explanation for the early lethality of XO
embryos is a haploinsufficiency effect of pseudoautosomal genes on
the X chromosome. Therefore, we suggest that pseudoautosomal
genes on the X chromosome have an important role in placental
development. Two X linked genes that escape X inactivation are
highly enriched in the placenta – STS and CSF2RA
(NM_006140). Based on 39,XO mouse model, the STS gene
has been suggested to play a role in the phenotype of Turner’s
syndrome patients [38]. However the human STS gene has no
active homologue on the Y chromosome [39], and therefore it is
not likely that haploinsufficiency of this gene causes the placental
phenotype. The CSF2RA (colony-stimulating factor 2 receptor
alpha) gene is an excellent candidate gene to explain the placental
phenotype. This gene encodes the alpha subunit of the receptor of
granulocyte-macrophage colony-stimulating factor (GMCSF
NM_000758) which is essential for normal placental development
[40]. Therefore, it is possible that haploissuficiency of the receptor
(CSF2RA) will result in abnormal placental differentiation.
Theoretically, the expression level of pseudoautosomal gene is
supposed to be 2 fold higher in XX cells than in XO cells, however
according to the qRTPCR results the CSF2RA gene is expressed
9.5 fold higher in the XX cells than in the XO cells (see Figure 4).
We assume that the low expression levels in the XO cells is as a
result of the unsuccessful placental differentiation of the XO
HESCs. The outcome of the haploinsufficiency of CSF2RA
(which result from relatively minor decrease in the expression level
of the gene) may cause a general defect in placental differentiation
and down regulation of many placental genes included CSF2RA
itself. The fact that XO mice are fertile and healthy suggests that
the genes involved in the human XO phenotypes (included the
early lethality) are either autosomal or undergo X inactivation in
mice and thus there is no haploinsufficiency effect for this gene in
XO mice [11]. Indeed, the CSF2RA gene is autosomal in mice
and resides on chromosome 19.
In conclusion, we suggest that the embryonic lethality in XO
embryos results from a defect in placental differentiation. The
defect may be a consequence of haploinsufficiency in the
expression of a placental gene that resides on the X chromosome
specifically in humans.
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